Loading organizations...
Loading organizations...
Develops novel pharmaceuticals using natural product-like macrocycles.
Rapafusyn Pharmaceuticals has raised $72.0M across 2 funding rounds.
Rapafusyn Pharmaceuticals has raised $72.0M in total across 2 funding rounds.
Rapafusyn Pharmaceuticals has raised $72.0M in total across 2 funding rounds.
Rapafusyn Pharmaceuticals's investors include Karen Liu, Jian Li, Haolin Sung, Wen Chen, Proxima Ventures, Zhihua Yu.
Rapafusyn Pharmaceuticals has raised $72.0M across 2 funding rounds. Most recently, it raised $44.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 8, 2025 | $44.0M Series A | Karen Liu, Jian Li, Haolin Sung, Wen Chen | |
| Jun 24, 2024 | $28.0M Series A | Karen Liu, Proxima Ventures | Zhihua Yu |